Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 17

1.

Controlled attenuation parameter (CAP) for the diagnosis of steatosis: a prospective study of 5323 examinations.

de Lédinghen V, Vergniol J, Capdepont M, Chermak F, Hiriart JB, Cassinotto C, Merrouche W, Foucher J, Brigitte le B.

J Hepatol. 2014 May;60(5):1026-31. doi: 10.1016/j.jhep.2013.12.018. Epub 2013 Dec 28.

PMID:
24378529
[PubMed - in process]
2.

Impact of mucosal healing on long-term outcomes in ulcerative colitis treated with infliximab: a multicenter experience.

Laharie D, Filippi J, Roblin X, Nancey S, Chevaux JB, Hébuterne X, Flourié B, Capdepont M, Peyrin-Biroulet L.

Aliment Pharmacol Ther. 2013 May;37(10):998-1004. doi: 10.1111/apt.12289. Epub 2013 Mar 21.

PMID:
23521659
[PubMed - indexed for MEDLINE]
3.

Pancreaticoduodenectomy following chemoradiotherapy for locally advanced adenocarcinoma of the pancreatic head.

Denost Q, Laurent C, Adam JP, Capdepont M, Vendrely V, Collet D, Cunha AS.

HPB (Oxford). 2013 Sep;15(9):716-23. doi: 10.1111/hpb.12039. Epub 2013 Jan 10.

PMID:
23458326
[PubMed - indexed for MEDLINE]
4.

Clinical, but not oesophageal pH-impedance, profiles predict response to proton pump inhibitors in gastro-oesophageal reflux disease.

Zerbib F, Belhocine K, Simon M, Capdepont M, Mion F, Bruley des Varannes S, Galmiche JP.

Gut. 2012 Apr;61(4):501-6. doi: 10.1136/gutjnl-2011-300798. Epub 2011 Oct 13.

PMID:
21997546
[PubMed - indexed for MEDLINE]
5.

Risk factors for fecal incontinence after intersphincteric resection for rectal cancer.

Denost Q, Laurent C, Capdepont M, Zerbib F, Rullier E.

Dis Colon Rectum. 2011 Aug;54(8):963-8. doi: 10.1097/DCR.0b013e31821d3677.

PMID:
21730784
[PubMed - indexed for MEDLINE]
6.

Prediction of Crohn's disease relapse with faecal calprotectin in infliximab responders: a prospective study.

Laharie D, Mesli S, El Hajbi F, Chabrun E, Chanteloup E, Capdepont M, Razaire S, de Lédinghen V, Zerbib F.

Aliment Pharmacol Ther. 2011 Aug;34(4):462-9. doi: 10.1111/j.1365-2036.2011.04743.x. Epub 2011 Jun 14.

PMID:
21671970
[PubMed - indexed for MEDLINE]
7.

Mucosal healing with methotrexate in Crohn's disease: a prospective comparative study with azathioprine and infliximab.

Laharie D, Reffet A, Belleannée G, Chabrun E, Subtil C, Razaire S, Capdepont M, de Lédinghen V.

Aliment Pharmacol Ther. 2011 Mar;33(6):714-21. doi: 10.1111/j.1365-2036.2010.04569.x. Epub 2011 Jan 16.

PMID:
21235604
[PubMed - indexed for MEDLINE]
8.

Combined approach with infliximab, surgery, and methotrexate in severe fistulizing anoperineal Crohn's disease: results from a prospective study.

Roumeguère P, Bouchard D, Pigot F, Castinel A, Juguet F, Gaye D, Capdepont M, Zerbib F, Laharie D.

Inflamm Bowel Dis. 2011 Jan;17(1):69-76. doi: 10.1002/ibd.21405.

PMID:
20623697
[PubMed - indexed for MEDLINE]
9.

Impact of tumor response on survival after radiochemotherapy in locally advanced rectal carcinoma.

Rullier A, Laurent C, Capdepont M, Vendrely V, Bioulac-Sage P, Rullier E.

Am J Surg Pathol. 2010 Apr;34(4):562-8. doi: 10.1097/PAS.0b013e3181d438b0.

PMID:
20216380
[PubMed - indexed for MEDLINE]
10.

Long-term wound advantages of the laparoscopic approach in rectal cancer.

Laurent C, Leblanc F, Bretagnol F, Capdepont M, Rullier E.

Br J Surg. 2008 Jul;95(7):903-8. doi: 10.1002/bjs.6134.

PMID:
18551506
[PubMed - indexed for MEDLINE]
11.

[Interest of radiotherapy of rectal cancer with synchronous metastases].

Tournat H, Vendrely V, Cherciu B, Smith D, Laurent C, Capdepont M, Kantor G, Maire JP.

Cancer Radiother. 2008 Sep;12(5):336-42. doi: 10.1016/j.canrad.2008.01.005. Epub 2008 Mar 18. French.

PMID:
18353701
[PubMed - indexed for MEDLINE]
12.

Lymph nodes after preoperative chemoradiotherapy for rectal carcinoma: number, status, and impact on survival.

Rullier A, Laurent C, Capdepont M, Vendrely V, Belleannée G, Bioulac-Sage P, Rullier E.

Am J Surg Pathol. 2008 Jan;32(1):45-50.

PMID:
18162769
[PubMed - indexed for MEDLINE]
13.

Determinants of gastro-oesophageal reflux perception in patients with persistent symptoms despite proton pump inhibitors.

Zerbib F, Duriez A, Roman S, Capdepont M, Mion F.

Gut. 2008 Feb;57(2):156-60. Epub 2007 Oct 19.

PMID:
17951358
[PubMed - indexed for MEDLINE]
14.

The effect of body weight on altered expression of nuclear receptors and cyclooxygenase-2 in human colorectal cancers.

Delage B, Rullier A, Capdepont M, Rullier E, Cassand P.

Nutr J. 2007 Sep 3;6:20.

PMID:
17767717
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Relationship between the severity of hepatitis C virus-related liver disease and the presence of Helicobacter species in the liver: a prospective study.

Castéra L, Pedeboscq A, Rocha M, Le Bail B, Asencio C, de Lédinghen V, Bernard PH, Laurent C, Lafon ME, Capdepont M, Couzigou P, Bioulac-Sage P, Balabaud C, Mégraud F, Ménard A.

World J Gastroenterol. 2006 Dec 7;12(45):7278-84.

PMID:
17143941
[PubMed - indexed for MEDLINE]
Free Article
16.

Prognostic factors and longterm survival after hepatic resection for hepatocellular carcinoma originating from noncirrhotic liver.

Laurent C, Blanc JF, Nobili S, Sa Cunha A, le Bail B, Bioulac-Sage P, Balabaud C, Capdepont M, Saric J.

J Am Coll Surg. 2005 Nov;201(5):656-62. Epub 2005 Aug 31.

PMID:
16256906
[PubMed - indexed for MEDLINE]
17.

[Atrial natriuretic factor: one of the mechanisms of action of the phlebology bath at Barbotan].

Suffran J, Galen FX, Habrioux G, Norelle C, Mas D, Barbelet N, Bianchi C, Capdepont MT, Gautier D, Lachèze J, et al.

J Mal Vasc. 1991;16(2):99-104. French.

PMID:
1830607
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk